Tara Kieffer
Patrimonio netto: 494 627 $ in data 30/06/2026
Patrimonio netto: 494 627 $ in data 30/06/2026
Tara L.
Kieffer is Chief Product Strategy Officer at Enanta Pharmaceuticals, Inc. since 2024.
Formerly, Dr. Kieffer was VP-External Innovation & Business Development at Vertex Pharmaceuticals, Inc. from 2018 to 2020.
Education includes undergraduate studies at Colgate University and a doctorate from The Johns Hopkins University School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/02/2026 | 33.925 ( 0,12% ) | 494 627 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 08/12/2020 |
| Società | Posizione | Fine |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/10/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Colgate University
Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale